Issuance of Stock Acquisition Rights
First written in FY2017-Q2. 14 of 21 entries say "Restated". Latest entry: FY2026-H1.
The whole theme swung hardest in 2026: 1 of 10 companies on the "Worse" side.
1 other company's latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「① [Details of the stock option plan] Not applicable. ② [Status of other stock acquisition rights, etc.] Not applicable.」
The disclosure continues to state that no new stock acquisition rights or similar instruments were issued during the interim accounting period. - FY2024-Q3RestatedAnnual report
「① [Details of the stock option plan] Not applicable. ② [Status of other stock acquisition rights, etc.] Not applicable.」
The disclosure continues to state that no new stock acquisition rights or similar instruments were issued during the third quarter accounting period. - FY2024-Q2RestatedAnnual report
「① [Details of the stock option plan] Not applicable. ② [Status of other stock acquisition rights, etc.] Not applicable.」
The disclosure continues to state that no new stock acquisition rights or similar instruments were issued during the second quarter accounting period. - FY2024-Q1RestatedAnnual report
「① [Details of the stock option plan] Not applicable. ② [Status of other stock acquisition rights, etc.] Not applicable.」
The disclosure continues to state that no new stock acquisition rights or similar instruments were issued during the first quarter accounting period. - FY2023RestatedAnnual report
「As the stock-based compensation stock option plan was abolished at the 49th Annual General Meeting of Shareholders held on 24 June 2021, no new stock options have been granted since then.」
Following the abolition of the stock option plan, the policy of making no new grants continued to be stated in the annual disclosure. Balances of stock options granted from 2007 through 2020 remain disclosed. - FY2023-Q3RestatedAnnual report
「① [Details of the stock option plan] Not applicable. ② [Status of other stock acquisition rights, etc.] Not applicable.」
The disclosure continues to state that no new stock acquisition rights or similar instruments were issued during the third quarter accounting period. - FY2022DroppedAnnual report
「As the stock-based compensation stock option plan was abolished at the 49th Annual General Meeting of Shareholders held on 24 June 2021, no new stock options have been granted since then.」
The existing balance of stock acquisition rights was disclosed, but the stock-based compensation stock option plan was abolished and the company explicitly stated its policy of making no new grants. - FY2022-Q2RestatedAnnual report
「① [Details of the stock option plan] Not applicable. ② [Status of other stock acquisition rights, etc.] Not applicable.」
The disclosure continues to state that no new stock acquisition rights or similar instruments were issued during the second quarter accounting period. - FY2022-Q1RestatedAnnual report
「① [Details of the stock option plan] Not applicable. ② [Status of other stock acquisition rights, etc.] Not applicable.」
The disclosure continues to state that no new stock acquisition rights or similar instruments were issued during the first quarter accounting period. - FY2021-Q3RestatedAnnual report
「① [Details of the stock option plan] Not applicable. ② [Status of other stock acquisition rights, etc.] Not applicable.」
The disclosure continues to state that no new stock acquisition rights or similar instruments were issued during the third quarter accounting period. - FY2021-Q2AdvancedAnnual report
「Resolution date 25 June 2020 Categories and number of eligible persons (people) Directors of the Company 5 Directors of the Company's subsidiaries 5 Number of stock acquisition rights (units)* 1,875 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 187,500 (Note 2) Exercise period for the stock acquisition rights* From 20 August 2020 to 19 August 2050」
The company disclosed the issuance of 1,875 stock acquisition rights, representing 187,500 underlying shares, based on the resolution of 25 June 2020. - FY2021-Q1RestatedAnnual report
「① [Details of the stock option plan] Not applicable. ② [Status of other stock acquisition rights, etc.] Not applicable.」
The disclosure continues to state that no new stock acquisition rights or similar instruments were issued during the first quarter accounting period. - FY2020-Q2AdvancedAnnual report
「Resolution date 25 June 2019 Categories and number of eligible persons (people) Directors of the Company 5 Directors of the Company's subsidiaries 5 Number of stock acquisition rights (units)* 1,875 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 187,500 (Note 2) Exercise period for the stock acquisition rights* From 17 August 2019 to 16 August 2049」
The company disclosed the issuance of 1,875 stock acquisition rights, representing 187,500 underlying shares, based on the resolution of 25 June 2019. This was a new issuance following the 2018 Stock Options. - FY2019RestatedAnnual report
「l. 2018 Stock Options Resolution date 26 June 2018 Number of stock acquisition rights (units)* 1,457 Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 145,700 (Note 2)」
The terms of the 2018 Stock Options were republished in the annual disclosure. The balance of stock acquisition rights increased from ¥430 million at the end of the previous fiscal year to ¥505 million. - FY2019-Q3RestatedAnnual report
「① [Details of the stock option plan] Not applicable. ② [Status of other stock acquisition rights, etc.] Not applicable.」
The disclosure continued to state that there were no applicable issuances of stock options, other stock acquisition rights or similar instruments during the third quarter accounting period. - FY2019-Q2AdvancedAnnual report
「Date of resolution 26 June 2018 Number of stock acquisition rights (units)* 1,457 Class, terms and number of shares underlying the stock acquisition rights (shares)* Common shares 145,700 Exercise period for the stock acquisition rights* From 19 August 2018 to 18 August 2048」
The filing disclosed the details of the issuance of 1,457 stock acquisition rights representing 145,700 underlying shares, based on the resolution dated 26 June 2018. - FY2019-Q1RestatedAnnual report
「Not applicable.」
The company stated that no stock options, other stock acquisition rights or similar instruments were issued during the first quarter accounting period. - FY2018RestatedAnnual report
「2017 stock options Number of stock acquisition rights (units) 1,480 Number of shares underlying the stock acquisition rights (shares) 148,000 Exercise period for the stock acquisition rights From 1 September 2017 to 31 August 2045」
The remaining details of stock acquisition rights, including the 2017 stock options, were reproduced in the annual disclosure. - FY2018-Q3No stock acquisition rights issuedAnnual report
「Not applicable.」
The company stated that there were no applicable issuances of stock acquisition rights or similar instruments during the third quarter accounting period. - FY2018-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows. Date of resolution 20 July 2017 Number of stock acquisition rights (units) 1,480 (Note 1) Number of shares underlying the stock acquisition rights (shares) 148,000 (Note 2) Exercise period for the stock acquisition rights From 1 September 2017 To 31 August 2047」
Based on the resolution dated 20 July 2017, 1,480 stock acquisition rights representing 148,000 underlying shares were issued. The filing reports a new issuance. - FY2017-Q2First statedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows. Date of resolution 28 June 2016 Number of stock acquisition rights (units) 1,555 (Note 1) Number of shares underlying the stock acquisition rights (shares) 155,500 (Note 2) Exercise period for the stock acquisition rights From 1 August 2016 To 31 July 2046」
Issued 1,555 stock acquisition rights representing 155,500 underlying shares. The exercise period runs from 1 August 2016 to 31 July 2046.